Immunohistochemical expression of p16, p53, and p63 in colorectal adenomas and adenocarcinomas

Diseases of the Colon and Rectum

Volumn 49, Issue 5, 2006, Pages 588-594

  Carneiro, Fabiana Pirani ^a   Ramalho, Leandra Náira Zambelli ^a   Britto Garcia, Sérgio ^a   Ribeiro Silva, Alfredo ^a   Zucoloto, Sérgio ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Adenocarcinoma; Adenoma; p16; p53; p63

Indexed keywords

CYTOKERATIN 5; PROTEIN ANTIBODY; PROTEIN P16; PROTEIN P53; PROTEIN P63; TUMOR MARKER;

ADENOMATOUS POLYP; ANTIBODY LABELING; ARTICLE; CANCER CLASSIFICATION; CANCER GRADING; COLORECTAL ADENOCARCINOMA; COLORECTAL ADENOMA; COLORECTAL CARCINOMA; DOUBLE IMMUNOLABELING; DYSPLASIA; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; POORLY DIFFERENTIATED ADENOCARCINOMA; PROTEIN EXPRESSION; TECHNIQUE; TUBULAR VILLOUS ADENOMA; TUMOR DIFFERENTIATION; VILLOUS ADENOMA;

ADENOCARCINOMA; ADENOMA; COLORECTAL NEOPLASMS; DNA-BINDING PROTEINS; GENES, P16; GENES, P53; GENES, TUMOR SUPPRESSOR; HUMANS; IMMUNOHISTOCHEMISTRY; KERATINS; PHOSPHOPROTEINS; TRANS-ACTIVATORS; TUMOR MARKERS, BIOLOGICAL; TUMOR SUPPRESSOR PROTEINS;

EID: 33646574948     PISSN: 00123706     EISSN: 15300358     Source Type: Journal    
DOI: 10.1007/s10350-006-0515-4     Document Type: Article

References (36)

1. DM Parkin F Bray J Ferlay P Pisani 2005 Global cancer statistics, 2002 CA Cancer J Clin 55 74 108
2. S Srivastava M Verma DE Henson 2001 Biomarkers for early detection of colon cancer Clin Cancer Res 7 1118 1126
3. A Rashid L Shen JS Morris JP Issa SR Hamilton 2001 CpG island methylation in colorectal adenomas Am J Pathol 159 1129 1135
4. JH Bond 2000 Polyp guideline: diagnosis, treatment and surveillance for patients with colorectal polyps Am J Gastroenterol 95 3053 3063
5. MJ O'Brien SJ Winawer AG Zauber 1990 The national polyp study. Patient and polyp characteristics associated with high-grade dysplasia in colorectal adenomas Gastroenterology 98 371 379
6. J Gayet XP Zhou A Duval S Rolland JM Hoang P Cottu R Hamelin 2001 Extensive characterization of genetic alterations in a series of human colorectal cancer cell lines Oncogene 36 5025 5032
7. A Okamoto DJ Demetrick EA Spillare 1994 Mutations and altered expression of p16INK4 in human cancer Proc Natl Acad Sci USA 23 11045 11049
8. N Burri P Shaw H Bouzourene 2001 Methylation silencing and mutations of the p14ARF and p16INK4a genes in colon cancer Lab Invest 2 217 229
9. K Harms S Nozell X Chen 2004 The common and distinct target genes of the p53 family transcription factors Cell Mol Life Sci 61 822 842
10. UM Moll N Slade 2004 P63 and p73: roles in development and tumor formation Mol Cancer Res 2 371 386
11. G Blandino M Dobbelstein 2004 P73 and p63: why do we still need them? Cell Cycle 3 886 894
12. AJ Levine AJ Levine J Momand CA Finlay 1991 The p53 tumour suppressor gene Nature 351 453 456
13. CJ Di Como MJ Urist I Babayan 2002 P63 expression profiles in human normal and tumor tissues Clin Cancer Res 2 494 501
14. JS Reis-Filho PT Simpson A Martins A Preto F Gartner FC Schmitt 2003 Distribution of p63, cytokeratins 5/6 and cytokeratin 14 in 51 normal and 400 neoplastic human tissue samples using TARP-4 multi-tumor tissue microarray Virchows Arch 2 122 132
15. K Nylander B Vojtesek R Nenutil 2002 Differential expression of p63 isoforms in normal tissues and neoplastic cells J Pathol 4 417 427
16. L Lo Muzio A Santarelli R Caltabiano 2005 P63 overexpression associates with poor prognosis in head and neck squamous cell carcinoma Hum Pathol 2 187 194
17. A Ribeiro-Silva LN Zambelli Ramalho S Britto Garcia S Zucoloto 2003 The relationship between p63 and p53 expression in normal and neoplastic breast tissue Arch Pathol Lab Med 3 336 340
18. MP Foschini A Gaiba R Cocchi MG Pennesi MR Gatto GP Frezza A Pession 2004 Pattern of p63 expression in squamous cell carcinoma of the oral cavity Virchows Arch 4 332 339
19. LD Davis W Zhang A Merseburger 2002 P63 expression profile in normal and malignant prostate epithelial cells Anticancer Res 22 3819 3825
20. M Tsujita-Kyutoku K Kiuchi N Danbara T Yuri H Senzaki A Tsubura 2003 P63 expression in normal human epidermis and epidermal appendages and their tumors J Cutan Pathol 1 11 17
21. BY Wang J Gil D Kaufman L Gan DS Kohtz DE Burstein 2002 P63 in pulmonary epithelium, pulmonary squamous neoplasms, and other pulmonary tumors Hum Pathol 9 921 926
22. JS Reis-Filho B Torio A Albergaria FC Schmitt 2002 P63 expression in normal skin and usual cutaneous carcinomas J Cutan Pathol 9 517 523
23. JN Glickman A Yang A Shahsafaei F [tmp] McKeon RD Odze 2001 Expression of p53-related protein p63 in the gastrointestinal tract and in esophageal metaplastic and neoplastic disorders Hum Pathol 11 1157 1165
24. A Tannapfel S Schmelzer M Benicke 2001 Expression of the p53 homologues p63 and p73 in multiple simultaneous gastric cancer J Pathol 2 163 170
25. Y Ito T Takeda K Wakasa M Tsujimoto M Sakon N Matsuura 2001 Expression of p73 and p63 proteins in pancreatic adenocarcinoma: p73 overexpression is inversely correlated with biological aggressiveness Int J Mol Med 1 67 71
26. JT O'Connell GL Mutter A Cviko 2001 Identification of a basal/reserve cell immunophenotype in benign and neoplastic endometrium: a study with the p53 homologue p63 Gynecol Oncol 1 30 36
27. PA Hall AC Woodman SJ Campbell NA Shepherd 2001 Expression of the p53 homologue p63alpha and DeltaNp63alpha in the neoplastic sequence of Barrett's oesophagus: correlation with morphology and p53 protein Gut 5 618 623
28. R Parsa A Yang F [tmp] McKeon H Green 1999 Association of p63 with proliferative potential in normal and neoplastic human keratinocytes J Invest Dermatol 6 1099 1105
29. A Yang M Kaghad Y Wang 1998 P63, a p53 homolog at 3q27-29, encodes multiple products with transactivating, death-inducing, and dominant-negative activities Mol Cell 3 305 316
30. P Visca PL Alo F Del Nonno 1999 Immunohistochemical expression of fatty acid synthase, apoptotic-regulating genes, proliferating factors, and ras protein product in colorectal adenomas, carcinomas, and adjacent nonneoplastic mucosa Clin Cancer Res 12 4111 4118
31. A Yamaguchi Y Kurosaka S Fushida M Kanno Y Yonemura K Miwa I Miyazaki 1992 Expression of p53 protein in colorectal cancer and its relationship to short-term prognosis Cancer 12 2778 2784
32. E Campo O De la Calle-Martin R Miquel 1991 Loss of heterozygosity of p53 gene and p53 protein expression in human colorectal carcinomas Cancer Res 16 4436 4442
33. G Lanza Jr I Maestri A Dubini R Gafa A Santini S Ferretti L Cavazzini 1996 P53 expression in colorectal cancer: relation to tumor type, DNA ploidy pattern and short-term survival Am J Clin Pathol 5 604 612
34. M Serrano GJ Hannon D Beach 1993 A new regulatory motif in cell cycle control causing specific inhibition of cyclin D/CDK4 Nature 366 704 707
35. T Tada T Watanabe S Kazama T Kanazawa K Hata Y Komuro H Nagawa 2003 Reduced p16 expression correlates with lymphatic invasion in colorectal cancers Hepatogastroenterology 54 1756 1760
36. CY Dai EE Furth R Mick J Koh T Takayama Y Niitsu GH Enders 2000 P16 expression begins early in human colon neoplasia and correlates inversely with markers of cell proliferation Gastroenterology 119 929 942